Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Immunoglobulins Market?

The market size for immunoglobulins has experienced robust growth in the recent past. Projections show an increase from $18.85 billion in 2024 to $20.32 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.8%. The substantial growth in the previous period is linked to the rising occurrence of immunodeficiency disorders, an expanding elderly population, the increasing use of immunoglobulins in hospital settings, beneficial government reimbursement programs, and an increase in chronic and autoimmune diseases.

In the coming years, the immunoglobulins market size is projected to observe significant growth, escalating to “$30.89 billion in 2029 with a compound annual growth rate (CAGR) of 11.0%. This growth during the forecast period is primarily due to the surge in investment towards innovative technology development, heightened awareness surrounding immunodeficiency treatments, physicians’ increasing reliance on immunodeficiency treatments, the rise of new markets and widened applications in sports and fitness. Leading trends to watch for during the forecast period consist of the creation of wearable and smart compression devices, personalization of compression therapy solutions, compression therapy integration in wound care management, a focus on patient comfort and compliance in compression therapy, and collaboration between manufacturers and healthcare providers to enhance patient outcomes.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp

What Are The Primary Factors Supporting The Immunoglobulins Market Expansion?

The escalation in the elderly population is driving the expansion of the immunoglobulins market. This age demographic is exceptionally susceptible to infectious and auto-immune diseases. The test for immunoglobulin assesses the capacity of the body to generate antibodies for defense against bacteria, viruses, and allergies. As an example, a report from the World Health Organization (WHO), a Swiss-based entity accountable for global public health, predicted in October 2022 that by 2030, one out of every six individuals around the world will be 60 or above. The prediction extends to 2050, when there will be 2.1 billion people globally aged 60 or more. Accordingly, the demographic growth of the older population is forecasted to amplify demand in the immunoglobulins market.

Which Segments Define The Structure Of The Immunoglobulins Market?

The immunoglobulins market covered in this report is segmented –

1) By Product: IGG, IGA, IGM, IGE, IGD.

2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications

Subsegments:

1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin), SCIG (Subcutaneous Immunoglobulin)

2) By IGA (Immunoglobulin A): Monoclonal IGA, Polyvalent IGA

3) By IGM (Immunoglobulin M): Monoclonal IGM, Polyvalent IGM

4) By IGE (Immunoglobulin E): Allergen-Specific IGE, Monoclonal IGE

5) By IGD (Immunoglobulin D): Research-Use IGD, Monoclonal IGD

What Strategic Shifts And Innovations Are Influencing The Immunoglobulins Market?

Key businesses in the immunoglobulins sector are focusing on innovation and new product creation, like intravenous immunoglobulins, in an attempt to reach a larger audience, boost sales, and elevate earnings. In September 2024, for example, GC Biopharma, a biotech firm based in South Korea, introduced their product ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid to the U.S. market. This product aims to treat primary humoral immunodeficiency (PI) in adults who are 17 years or older and can be accessed via specialty pharmacies. The introduction is pivotal since the U.S. has the biggest immunoglobulin market worldwide, standing at an estimated value of $11.6 billion. GC Biopharma has set its sights on reaching $50 million in ALYGLO sales in its inaugural year, with a goal to elevate this number to $300 million by 2028. Their aggressive expansion plan includes collaborations with significant U.S. pharmacy benefit managers and specialty pharmacies, which are essential for the effective distribution of immunoglobulin products.

Who Are The Primary Market Leaders In The Immunoglobulins Market?

Major companies operating in the immunoglobulins market include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

What Regional Factors Are Accelerating Growth In The Immunoglobulins Market?

North America was the largest region in the immunoglobulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=5284&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model